Cargando…
Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518962/ https://www.ncbi.nlm.nih.gov/pubmed/28781610 http://dx.doi.org/10.1177/1756285617717155 |
| _version_ | 1783251557123358720 |
|---|---|
| author | Dalakas, Marinos C. |
| author_facet | Dalakas, Marinos C. |
| author_sort | Dalakas, Marinos C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5518962 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55189622017-08-05 Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost Dalakas, Marinos C. Ther Adv Neurol Disord Editorial SAGE Publications 2017-06-28 2017-08 /pmc/articles/PMC5518962/ /pubmed/28781610 http://dx.doi.org/10.1177/1756285617717155 Text en © The Author(s), 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm). |
| spellingShingle | Editorial Dalakas, Marinos C. Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title | Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title_full | Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title_fullStr | Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title_full_unstemmed | Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title_short | Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| title_sort | gene therapy for duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518962/ https://www.ncbi.nlm.nih.gov/pubmed/28781610 http://dx.doi.org/10.1177/1756285617717155 |
| work_keys_str_mv | AT dalakasmarinosc genetherapyforduchennemusculardystrophybalancinggoodsciencemarginalefficacyhighemotionsandexcessivecost |